From: Community- versus hospital-acquired acute kidney injury in hospitalised COVID-19 patients
Covariates | Adjusted hazard ratio | 95% confidence intervals | Pvalue |
---|---|---|---|
Stage 1: Pre-admission factors | |||
Age (in decades) | 1.37 | 1.20 – 1.56 | <0.0001 |
Clinical frailty score | 1.18 | 1.07 – 1.31 | 0.002 |
Obesity | 1.57 | 1.05 – 2.34 | 0.029 |
Stage 2: Pre-admission and admission factors (including community-acquired AKI) | |||
Age (in decades) | 1.33 | 1.16 – 1.53 | <0.0001 |
Clinical frailty score | 1.24 | 1.12 – 1.38 | <0.0001 |
Admission O2 saturation | 0.95 | 0.92 – 0.97 | <0.0001 |
Admission respiratory rate | 1.06 | 1.03 – 1.08 | <0.0001 |
Admission CRP (per 10 units) | 1.03 | 1.01 – 1.04 | 0.005 |
Stage 3: Pre-admission, admission and inpatient factors (including hospital-acquired AKI) | |||
Age (in decades) | 1.35 | 1.18 – 1.55 | <0.0001 |
Clinical frailty score | 1.26 | 1.13 – 1.41 | <0.0001 |
Admission O2 saturation | 0.95 | 0.93 – 0.98 | <0.0001 |
Admission respiratory rate | 1.04 | 1.02 – 1.07 | <0.0001 |
Hospital-acquired AKI | 4.64 | 2.98 – 7.23 | <0.0001 |
Peak CRP (per 10 units) | 1.05 | 1.03 - 1.06 | <0.0001 |
Trough lymphocytes | 1.14 | 1.03 – 1.26 | 0.015 |